Endocrine Reviews Editorial Team
Editor-in-Chief
Ashley Grossman, MD, FRCP, FMedSci
University of Oxford
Oxford, United Kingdom
Professor Grossman is Professor of Endocrinology and Fellow of Green-Templeton College at the University of Oxford, Professor of Neuroendocrinology at St. Bartholomew’s Hospital and the London School of Medicine and Dentistry, and Consultant Neuroendocrine Tumour Endocrinologist at the Royal Free Hospital, London. His current interests revolve around the pathogenesis of endocrine tumors, including adrenal, pituitary, and neuroendocrine tumors. He was awarded the Clinical Endocrinology Trust prize lecture in 2004, the European Society for Endocrinology Geoffrey Harris Prize in 2014, and the Iain MacIntyre Prize at Barts and the London in 2017. He has been President of the European Neuroendocrine Association, the Pituitary Society (2015–2016) and the Society for Endocrinology (2012–2014), as well as Chairman of the UK and Ireland Neuroendocrine Tumour Society (2010–2012). He is author or co-author of some 900 original articles and reviews.
Deputy Editor
E. Dale Abel, MD, PhD
David Geffen School of Medicine, University of California Los Angeles
Los Angeles, CA, USA
Dr. Abel received his medical degree (MBBS) with Distinction from the University of the West Indies, then went to the University of Oxford as a Rhodes Scholar, where he obtained his DPhil. He is the William S. Adams Distinguished Professor of Medicine, Chair and Executive Medical Director, Department of Medicine, David Geffen School of Medicine and UCLA Health. Prior to moving to UCLA, Dr. Abel was the Chair and Department Executive Officer of the Department of Internal Medicine and Director of the Fraternal Order of Eagles Diabetes Research Center at the University of Iowa, where he was a Professor of Medicine, of Biochemistry, and of Biomedical Engineering. He held the John B. Stokes III Chair in Diabetes Research and the François M. Abboud Chair in Internal Medicine. Dr. Abel’s pioneering work on glucose transport and mitochondrial metabolism in the heart guides his current research interests: molecular mechanisms responsible for cardiovascular complications of diabetes. His laboratory has provided important insights into the contribution of mitochondrial dysfunction and aberrant insulin signaling to heart failure risk in diabetes. Recent work has focused on mitochondrial mechanisms that mediate inter-organ crosstalk and may influence the pathophysiology of insulin resistance, and mitochondrial pathways linking metabolism with increased risk for atherothrombosis. Dr. Abel is an elected member of the American Association of Physicians (AAP), the American Society for Clinical Investigation (ASCI), National Academy of Medicine (NAM), and the American Clinical and Climatological Association (ACCA). Dr. Abel is President of the Association of Professors of Medicine (APM) for the 2021-2022 term.
Associate Editors
Roderick J. Clifton-Bligh, MBBS, PhD, FRACP
The University of Sydney and Royal North Shore Hospital
Sydney, Australia
Associate Professor Roderick Clifton-Bligh is Head of the Department of Endocrinology at Royal North Shore Hospital, and conjoint associate professor in Medicine at the University of Sydney. He has been a clinician researcher since completing a PhD in the genetics of thyroid disorders at the University of Cambridge in 1998. His research focuses on the molecular bases of endocrine neoplasms, including thyroid cancer, phaechromocytoma/paraganglioma syndromes, adrenal cancer, and pituitary neoplasms. He has a strong clinical interest in hereditary endocrine neoplasia syndromes. He is passionate about teaching and mentoring young physicians and has supervised more than 14 completed PhDs. His work has been recognized by awards from NSW Cancer Institute (2013) and Asia-Oceania Thyroid Association (2014).
Anuja Dokras, MD, DPhil
University of Pennsylvania
Philadelphia, Pennsylvania, USA
Dr. Dokras received her medical degree from the University of Bombay, India. As a Rhodes scholar she obtained a DPhil from the University of Oxford, UK. She completed a residency in obstetrics and gynecology and fellowship training in reproductive endocrinology and infertility at Yale University. Dr. Dokras is currently professor of obstetrics and gynecology at the University of Pennsylvania, where she served as the medical director of the IVF program at Penn Fertility Care (2007-2013) and continues to Chair the Gynecology Team of the Women’s health Service Line and the Reproductive Surgical Facility. She is also the director of the multi-disciplinary Penn Polycystic Ovary Syndrome (PCOS) Center. Dr. Dokras's research program focuses on understanding the determinants of cardiovascular risk associated with PCOS at both the cellular and population level. Other areas of research include the impact of clinical interventions on metabolic risk, pregnancy, health-related quality of life, anxiety, and mood disorders in women with PCOS. Her work has been recognized by awards from the American Society of Reproductive Medicine. She is the past president and current Associate Executive Director of the Androgen Excess -PCOS Society.
Emma L. Duncan, MBBS, FRCP, FRACP, PhD, FAHMS, LMusA
King’s College London
London, United Kingdom
Professor Duncan studied medicine at the University of Sydney, and earned her PhD in Osteoporosis Genetics along with her completing her clinical training in endocrinology in Oxford, UK. In May 2020 she was appointed Professor of Clinical Endocrinology, King’s College London. Since her undergraduate days, she has been fascinated by endocrinology and the skeleton, and her research spans the genetics of many endocrine disorders, from common variant to rare monogenic diseases. She has played a pioneering role in translating genetic technologies (such as high-throughput microarray genotyping and massively parallel sequencing) into clinical practice. She has also published multiple clinical research papers. In the pandemic she has contributed to COVID-19 research, particularly COVID-19 in children and the post-COVID syndrome; and she co-leads the KCL COVID Symptom Study Biobank. She has served as President of the Australian and New Zealand Bone and Mineral Society and is currently serving on Council for the American Society for Bone and Mineral Research and as Associate Editor of the Journal of Bone and Mineral Research and Endocrine Reviews.
Lauren Fishbein, MD, PhD, MTR
University of Colorado School of Medicine
Aurora, Colorado, USA
Dr. Fishbein received her MD and PhD degrees from the University of Florida. She completed Internal Medicine Residency at Harvard’s Beth Israel Deaconess Medical Center and then moved to the University of Pennsylvania where she completed her Endocrinology Fellowship and a Master’s in Translational Research. Dr. Fishbein is currently an Associate Professor of Medicine at the University of Colorado School of Medicine in the Division of Endocrinology, Metabolism and Diabetes with a secondary appointment in the Division of Biomedical Informatics and Personalized Medicine. Dr. Fishbein has a strong interest in personalized medicine, including understanding the effect of germline predisposition genetics on endocrine tumor syndromes, as well as neuroendocrine tumor development and metastatic disease. Her research program focuses on investigating the interplay between somatic and germline genetics in neuroendocrine tumors, with a focus on pheochromocytoma and paraganglioma. She has served as chair on several committees for national and international societies, including the Endocrine Society, the North American Neuroendocrine Tumor Society, and the American-Australian-Asian-Adrenal Alliance (A5) research consortium’s Pheo/Para Working Group.
Peter A. Friedman, PhD
University of Pittsburgh
Pittsburgh, Pennsylvania, USA
Professor Friedman earned a PhD in pharmacology at the Upstate Medical Center and pursued postdoctoral training in biophysics at the Université de Lausanne and Cornell Medical School before accepting faculty positions first at the University of Texas Health Science Center at Houston and subsequently at Dartmouth Medical School. He is Professor of Pharmacology and Chemical Biology at the University of Pittsburgh School of Medicine. His laboratory is interested in the endocrinology of mineral-ion homeostasis and the mechanisms of PTH and FGF23 action, focusing on the role of PDZ scaffolding proteins in regulating signaling and function of membrane receptors and transporters. Current efforts are directed at elucidating the regulatory involvement of RGS14 in NPT2A-mediated phosphate transport and characterizing the underlying mechanism by which PTH and FGF23 control of phosphate transport may be additive or discrete. The laboratory uses a range of contemporary biochemical and molecular approaches including cell-free and cell-based systems, live cell fluorescence, mass spectrometry, molecular dynamics modeling, and proteomics to unravel the role of hormone-regulated phosphate transport.
Adriana G. Ioachimescu, MD, PhD
Medical College of Wisconsin
Milwaukee, Wisconsin, USA
Dr. Ioachimescu received her MD degree from University of Carol Davila of Medicine, Bucharest, Romania, in 1995 and her PhD from the same institution in 2001. She completed her internal medicine residency and endocrinology fellowship at Cleveland Clinic, Ohio, in 2006. Dr. Ioachimescu is currently a Professor in Medicine (Endocrinology) and Neurosurgery at the Medical College of Wisconsin and directs the pituitary and adrenal disease medicine program. Dr. Ioachimescu’s research is focused on investigation of long-term effects of pituitary hormone alterations on different organs and systems, as well as validation of prognostic markers and predictive models in patients with pituitary tumors. She has published multiple peer-reviewed articles, with a focus on acromegaly, prolactinoma, Cushing syndrome, and adrenal tumors. Dr. Ioachimescu has a passion for medical education and an extensive track record in research mentoring of students and trainees.
Noel P. Somasundaram, MBBS, MD, FRCP, FCCP, FSLCE
National Hospital of Sri Lanka
Colombo, Sri Lanka
Dr. Noel Somasundaram is Consultant Endocrinologist at the Diabetes and Hormone Centre, Colombo, Sri Lanka. He is the President of the South Asian Federation of Endocrine Societies (2019-2021) and Project Lead for the Sri Lanka Diabetes and Cardiovascular Initiative. Dr. Somasundaram has more than 100 publications in the field of diabetes, endocrinology, and metabolism. He is the editor of Clinical Diabetology, a handbook for diabetes management, and has chapters in fifteen textbooks including the Oxford Desktop Reference in Endocrinology and the International Textbook for Diabetes. He has been Principal investigator in many international studies, including the EMPAREG study. Dr. Somasundaram introduced to Sri Lanka comprehensive care for patients with diabetes, obesity, pituitary tumors, and craniopharyngioma, as well as hormone testing and catheter studies for complex endocrine disorders. He graduated (with honors) from the University of Jaffna and subsequently trained in the Endocrine Unit of St Bartholomew’s Hospital, London prior to being board certified as Endocrinologist by the Post Graduate Institute of Medicine, University of Colombo.
Katrin J. Svensson, PhD
Stanford University
Stanford, California, USA
Dr. Svensson is Assistant Professor of Pathology in the School of Medicine at Stanford University and the affinity group leader and member of the Stanford Diabetes Research Center. She received her PhD in 2012 from Lund University in Sweden and completed her postdoctoral studies at Harvard Medical School and the Dana-Farber Cancer Institute in Boston, Massachusetts, USA. Her laboratory studies the physiology and biochemistry of circulating factors and polypeptide hormones by using a combination of proteomics, cellular, and physiological approaches. She is a member of the Advisory Board at STAR Protocols, the American Diabetes Association, and the American Society for Biochemistry and Molecular Biology, and the recipient of the National Institutes of Health Pathway to Independence Award (2016).
Disclosure Information for the Editor-in-Chief, Deputy Editor, and Associate Editors
Publisher
Richard T. O’Grady, PhD
Executive Editor
Timothy M. Beardsley, DPhil
